Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
Cash Flows From Operating Activities | |||||
Net Income | -20,286 | -9,778 | -14,260 | -20,750 | -8,470 |
Depreciation Amortization | 123 | 197 | 680 | 860 | 1,220 |
Other Working Capital | 1,419 | -693 | -1,730 | 620 | -14,210 |
Other Operating Activity | 2,094 | -1,370 | 60 | 430 | 470 |
Operating Cash Flow | $-16,650 | $-11,644 | $-15,250 | $-18,840 | $-20,990 |
Cash Flows From Investing Activities | |||||
Change In Deposits | 285 | -19,843 | N/A | N/A | N/A |
PPE Investments | -230 | -33 | 70 | -10 | -240 |
Purchase Of Investment | N/A | 665 | N/A | N/A | N/A |
Other Investing Activity | 0 | 0 | 2,540 | 24,840 | 23,910 |
Investing Cash Flow | $55 | $-19,211 | $2,610 | $24,830 | $23,670 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 24,813 | 35,651 | N/A | N/A | N/A |
Other Financing Activity | 0 | -2,037 | 6,010 | 1,180 | 0 |
Financing Cash Flow | $24,813 | $33,614 | $6,010 | $1,180 | $0 |
Exchange Rate Effect | 303 | -278 | -10 | 100 | -80 |
Beginning Cash Position | 9,882 | 7,401 | 13,790 | 5,230 | 3,020 |
End Cash Position | 18,403 | 9,882 | 7,140 | 12,500 | 5,610 |
Net Cash Flow | $8,521 | $2,481 | $-6,650 | $7,270 | $2,580 |
Free Cash Flow | |||||
Operating Cash Flow | -16,650 | -11,644 | -15,250 | -18,840 | -20,990 |
Capital Expenditure | -230 | -110 | N/A | N/A | N/A |
Free Cash Flow | -16,880 | -11,754 | -15,250 | -18,840 | -20,990 |